Duke University v. Biomarin Pharmaceutical Inc.
Duke University v. Biomarin Pharmaceutical Inc.
Opinion
NOTE: This disposition is nonprecedential.
United States Court of Appeals for the Federal Circuit ______________________
DUKE UNIVERSITY, Appellant
v.
BIOMARIN PHARMACEUTICAL INC., Appellee ______________________
2018-1696 ______________________
Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2013- 00535. ______________________
JUDGMENT ______________________
STEVEN A. ZALESIN, Patterson Belknap Webb & Tyler LLP, New York, NY, argued for appellant. Also repre- sented by GEORGE B. FLEMING, EUGENE M. GELERNTER, ZHIQIANG LIU; IRENA ROYZMAN, Kramer Levin Naftalis & Frankel LLP, New York, NY.
GERALD MYERS MURPHY, JR., Birch Stewart Kolasch & Birch, LLP, Falls Church, VA, argued for appellee. Also represented by MARYANNE ARMSTRONG. ______________________ THIS CAUSE having been heard and considered, it is
ORDERED and ADJUDGED:
PER CURIAM (NEWMAN, LOURIE, and TARANTO, Cir- cuit Judges). AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT
October 11, 2019 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court
Reference
- Status
- Unpublished